Penlon today announced that it had completed the acquisition of Keomed Inc., and the Keomed group of companies, a respected U.S. distributor of Penlon anaesthesia systems and other anaesthesia supplies.
The Minnetonka MN, USA based Keomed Group (trading as Penlon - America) will join the UK based Penlon. Keomed will work closely with Penlon, a manufacturer and developer of anaesthesia systems, patient monitoring, laryngoscopes, suction, oxygen therapy devices and medical gas solutions, to further increase Penlon’s growing market share in the U.S.A.
“The acquisition of Keomed confirms Penlon’s long term commitment to the U.S. anaesthesia market and our determination to maximize U.S. sales”, said Simon Armstrong, CEO of Penlon.
Gavin Keogh, President and CEO of Keomed, welcomed the acquisition. “We are committed to this significant opportunity for growth and, as a Penlon company, will continue to partner with our customers and offer them top quality affordable anaesthesia solutions. “
Penlon, based in Abingdon UK, has been a successful anaesthesia company for more than 60 years. The company specializes in the design, manufacture and distribution of anaesthesia systems, vaporizers, ventilators, patient monitors, laryngoscopes, suction, oxygen therapy devices and medical gas solutions. Penlon distributes in over 90 countries.
In addition, Penlon is a leading supplier of OEM products and modules to anaesthesia and pharmaceutical companies worldwide.